SCHEMBL2168937

SCHEMBL2168937

O=C(O)ON1C(=O)C=CC1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DDAH1 O94760 1/20 0.35
NSD2 O96028 1/20 0.35
G6PD P11413 1/20 0.35
KEAP1 Q14145 1/20 0.35
NFE2L2 Q16236 1/20 0.35
ALDH1A1 P00352 2/20 0.34
CYP1A2 P05177 1/20 0.34
HPGD P15428 1/20 0.34
CYP2C19 P33261 1/20 0.34
BLM P54132 1/20 0.34
WRN Q14191 1/20 0.34
HIF1A Q16665 1/20 0.34
PTGS1 P23219 5/20 0.33
PTGS2 P35354 5/20 0.33
MGLL Q99685 5/20 0.33
GSK3A P49840 2/20 0.33
GSK3B P49841 2/20 0.33
FAAH O00519 1/20 0.31
HSP90AA1 P07900 2/20 0.31
PKM P14618 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL865686 0.81 ALDH1A1 (0.35) DDAH1NSD2G6PDKEAP1NFE2L2
SCHEMBL5071662 0.81 ALDH1A1 (0.35) DDAH1NSD2G6PDKEAP1NFE2L2
SCHEMBL4394188 0.79 ALDH1A1 (0.34) DDAH1NSD2G6PDKEAP1NFE2L2
SCHEMBL208215 0.77 ALDH1A1 (0.38) DDAH1NSD2G6PDKEAP1NFE2L2
SCHEMBL3694468 0.77 ALDH1A1 (0.33) DDAH1NSD2G6PDKEAP1NFE2L2
SCHEMBL6022398 0.77 NQO1 (0.34) DDAH1NSD2G6PDKEAP1NFE2L2
SCHEMBL21449752 0.77 ALDH1A1 (0.33) DDAH1NSD2G6PDKEAP1NFE2L2
SCHEMBL269178 0.75 ALDH1A1 (0.41) ALDH1A1CYP1A2HPGDCYP2C19BLM
SCHEMBL2581743 0.75 ALDH1A1 (0.41) NSD2G6PDKEAP1NFE2L2ALDH1A1
SCHEMBL1232813 0.75 GSK3A (0.35) KEAP1NFE2L2ALDH1A1CYP1A2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2126582-A2 METHOD FOR ASSAYING ANTIBODIES IN BODY FLUIDS BY IMMUNE REACTION WITH GLYCOPROTEIN 2 (GP2) FROM ZYMOGENIC GRANULES OF THE PANCREAS FOR THE DIFFERENTIAL DIAGNOSIS OF INFLAMMATORY INTESTINAL DISEASES AND CHRONIC PANCREATITIS GA Generic Assays GmbH (DE) 2009-12-02 EP claimed
WO-2008089756-A2 METHOD FOR ASSAYING ANTIBODIES IN BODY FLUIDS BY IMMUNE REACTION WITH GLYCOPROTEIN 2 (GP2) FROM ZYMOGENIC GRANULES OF THE PANCREAS FOR THE DIFFERENTIAL DIAGNOSIS OF INFLAMMATORY INTESTINAL DISEASES AND CHRONIC PANCREATITIS GA GENERIC ASSAYS GMBH (DE) 2008-07-31 WO claimed
EP-1603930-B1 PROTEIN-BOUND DERIVATIVES OF PLATINUM COMPLEXES CONTAINING CYCLOBUTANE 1.1-DICARBOXYLLATE LIGANDS KTB TUMORFORSCHUNGS GMBH (DE) 2007-08-29 EP claimed
EP-1332158-B1 PEPTIDES, THE PRODUCTION AND USE THEREOF FOR BINDING IMMUNOGLOBULINS FRESENIUS MEDICAL CARE AFFINA (DE) 2007-08-01 EP claimed
EP-1603930-A1 PROTEIN-BOUND DERIVATIVES OF PLATINUM COMPLEXES CONTAINING CYCLOBUTANE 1.1-DICARBOXYLLATE LIGANDS KTB Tumorforschungs GmbH (DE) 2005-12-14 EP claimed
WO-2004083223-A1 PROTEIN-BOUND DERIVATIVES OF PLATINUM COMPLEXES CONTAINING CYCLOBUTANE 1.1-DICARBOXYLLATE LIGANDS KTB TUMORFORSCHUNGS GMBH (DE) 2004-09-30 WO claimed
EP-1332158-A2 PEPTIDES, THE PRODUCTION AND USE THEREOF FOR BINDING IMMUNOGLOBULINS Affina Immuntechnik GmbH (DE) 2003-08-06 EP claimed
WO-2002038592-A2 PEPTIDES, THE PRODUCTION AND USE THEREOF FOR BINDING IMMUNOGLOBULINS AFFINA IMMUNTECHNIK GMBH (DE) 2002-05-16 WO claimed
EP-1086954-A1 Peptides against autoantibodies elicited by DCM Affina Immuntechnik GmbH (DE) 2001-03-28 EP claimed
EP-1086955-A1 Peptides against antibodies elicited by DCM Affina Immuntechnik GmbH (DE) 2001-03-28 EP claimed
EP-0336856-B1 WITH MALEIMIDE GROUPS FUNCTIONALIZED AROMATIC POLYAMIDEIMIDES, PROCESS FOR THEIR PREPARATION AND THEIR USE FOR PREPARING CROSS-LINKED POLYMERS CIBA-GEIGY AG (CH) 1993-03-03 EP claimed
EP-0403960-A2 Magnetic protein conjugates, method to make them and their use BEHRINGWERKE Aktiengesellschaft (DE) 1990-12-27 EP claimed
CN-118076596-A Five-membered and six-membered compound, preparation method, pharmaceutical composition and application 杭州多域生物技术有限公司 2024-05-24 CN disclosed
EP-1704864-B9 Injectable pharmaceutical preparation consisting of a cytostatic agent and a maleinimide linked by a spacer. KTB TUMORFORSCHUNGS GMBH (DE) 2012-09-19 EP disclosed
EP-1704864-B1 Injectable pharmaceutical preparation consisting of a cytostatic agent and a maleinimide linked by a spacer. KTB TUMORFORSCHUNGS GMBH (DE) 2012-05-23 EP disclosed
EP-2347770-A2 Process for producing an injectable pharmaceutical preparation KTB Tumorforschungs GmbH (DE) 2011-07-27 EP disclosed
WO-2000076551-A2 METHOD FOR PRODUCING AN INJECTABLE MEDICAMENT PREPARATION KTB TUMORFORSCHUNGS GMBH (DE) 2000-12-21 WO disclosed
EP-0298385-A2 Cyctostatic anthracyclin derivatives BEHRINGWERKE Aktiengesellschaft (DE) 1989-01-11 EP disclosed
EP-0062610-B1 PHOTOPOLYMERISATION PROCESS CIBA-GEIGY AG (CH) 1985-04-24 EP disclosed
EP-0062610-A2 Photopolymerisation process CIBA-GEIGY AG (CH) 1982-10-13 EP disclosed